New Strategies for New Psychoactive Substances: A Public Health Approach

New York, NY

The emergence of novel psychoactive substances (NPS) – ranging from synthetic cannabinoids such as K2, to synthetic opioids such as fentanyl, to traditional plants such as kratom – pose a number of challenges for policymakers, media covering these issues, medical and social service providers, and people who use these substances. Unfortunately, current media and policy responses to NPS have been largely fueled by misinformation rather than facts. 

This summit covered what is currently known about NPS, areas for future research, strategies for intervening when use becomes harmful, new forms of drug regulation, and how messaging and media about NPS can become more constructive. The summit laid the foundation for a series of recommendations for researchers, policymakers, medical and social service providers, and media.

View the program (PDF)

View summit recommendations (PDF)

View session videos


Drug Policy Alliance
The New School for Social Research Harm Reduction Psychotherapy Certificate Program
John Jay College of Criminal Justice


John & Laura Arnold
Center for Motivation and Change
Center for Optimal Living
Families for Sensible Drug Policies
New York State Psychological Association’s Division on Addiction


Columbia University Institute for Research in African-American Studies
HAMS: Harm Reduction for Alcohol
Harm Reduction Coalition
The Influence
Multidisciplinary Association for Psychedelic Studies (MAPS)
Picture the Homeless
New York Academy of Medicine
New York Harm Reduction Educators
Students for Sensible Drug Policy